[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
[ Fri, Feb 17th 2023 ]: WOPRAI
Ed Arce Reiterated (TVTX) at Strong Buy and Held Target at $36 on, Feb 17th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Ed Arce of HC Wainwright & Co., Reiterated "Travere Therapeutics, Inc." (TVTX) at Strong Buy and Held Target at $36 on, Feb 17th, 2023.
Ed has made no other calls on TVTX in the last 4 months.
There are 4 other peers that have a rating on TVTX. Out of the 4 peers that are also analyzing TVTX, 1 agrees with Ed's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Alex Thompson of "Stifel" Initiated at Hold and Held Target at $22 on, Wednesday, December 14th, 2022
These are the ratings of the 3 analyists that currently disagree with Ed
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $40 on, Monday, January 30th, 2023
- Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $42 on, Wednesday, January 11th, 2023
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $38 on, Thursday, October 20th, 2022